Postoperative liver dysfunction in living donors after left-sided graft hepatectomy: portal venous occlusion of the medial segment after lateral segmentectomy and hepatic venous congestion after left lobe hepatectomy

Transplant Proc. 2012 Mar;44(2):332-7. doi: 10.1016/j.transproceed.2012.01.023.

Abstract

Background: The aim of this study was to evaluate how sacrifice of the portal vein and/or hepatic vein affects remnant liver dysfunction after lateral segmentectomy or left lobe hepatectomy.

Materials and methods: Among 130 patients who underwent donor hepatectomy between March 2002 and July 2011, we enrolled lateral segment (n=15) and left lobe donors (n=40). We evaluated the postoperative courses and the territory of venous obstruction or congestion based on the sacrificed portal vein or hepatic vein after the donor operation: lateral segment grafts (P4a, P4b, LV4) and left lobe grafts (MV5, MV8) according to the results analyzed by MeVis Distant Service.

Results: Among lateral segment donors, the predicted sacrificed territory of portal vein and hepatic vein was 14.3% (7.3%-19.4%) in P4a+4b: (P4a: 8.6%, P4b: 5.8%) and 2.9% (0%-8.4%) in LV4, respectively. On the other hand, in left lobe donors, the predicted congestive territory of the hepatic vein was 17.6% (2.8%-33.0%) in MV5+8 (7.8% in MV5 and 9.8% in MV8, respectively). The incidence of patients whose postoperative peak aspartate aminotransferase (AST) or alanine aminotransferase levels were higher than 500 IU/L was 20% in the lateral segment donors and 5% in the left lobe donors. The peak postoperative AST levels and territory of MV5+8 showed a significant positive correlation (R=0.569, P<.05) among left lobe donors.

Conclusion: Territories of P4 in lateral segment donors and MV5+8 in left lobe donors impacted postoperative liver dysfunction. It is important to recognize the precise territory of the portal vein and the hepatic vein before the donor operation.

MeSH terms

  • Adolescent
  • Adult
  • Alanine Transaminase / blood
  • Analysis of Variance
  • Aspartate Aminotransferases / blood
  • Biomarkers / blood
  • Chi-Square Distribution
  • Female
  • Hepatectomy / adverse effects*
  • Hepatic Veins / diagnostic imaging
  • Hepatic Veins / physiopathology
  • Hepatic Veins / surgery*
  • Humans
  • Hyperemia / blood
  • Hyperemia / diagnostic imaging
  • Hyperemia / etiology*
  • Hyperemia / physiopathology
  • Japan
  • Liver Circulation*
  • Liver Diseases / blood
  • Liver Diseases / diagnostic imaging
  • Liver Diseases / etiology*
  • Liver Diseases / physiopathology
  • Liver Transplantation / adverse effects*
  • Living Donors*
  • Male
  • Middle Aged
  • Portal Vein / diagnostic imaging
  • Portal Vein / physiopathology
  • Portal Vein / surgery*
  • Predictive Value of Tests
  • Time Factors
  • Tomography, X-Ray Computed
  • Treatment Outcome
  • Up-Regulation
  • Young Adult

Substances

  • Biomarkers
  • Aspartate Aminotransferases
  • Alanine Transaminase